BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
92 results:

  • 1. Transcriptomic analysis of Porphyromonas gingivalis-infected head and neck cancer cells: Identification of PLAU as a candidate prognostic biomarker.
    Hamada M; Inaba H; Nishiyama K; Yoshida S; Yura Y; Matsumoto-Nakano M; Uzawa N
    J Cell Mol Med; 2024 Feb; 28(4):. PubMed ID: 38363001
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling.
    Li P; Yang L; Park SY; Liu F; Li AH; Zhu Y; Sui H; Gao F; Li L; Ye L; Zou Y; Tian Z; Zhao Y; Costa M; Sun H; Zhao X
    Oncogene; 2024 Mar; 43(12):899-917. PubMed ID: 38317006
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Protective Effect of Alpha-Linolenic Acid on Human Oral Squamous Cell Carcinoma Metastasis and Apoptotic Cell Death.
    Su CC; Yu CC; Shih YW; Liu KL; Chen HW; Wu CC; Yang YC; Yeh EL; Li CC
    Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068849
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma
    Wang L; Guo M; Gao L; Liu K; Bai J; Liu Z
    Curr Pharm Des; 2023; 29(37):2977-2987. PubMed ID: 37957865
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid cancer.
    Xie W; Li H; Lin Q; Ke N
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Qing Yan Li Ge Tang Induces Apoptosis in Human OEC-M1 Oral cancer Cells.
    Yang CH; Wu YT; Tung KL; Huang BM; Lan YY
    Altern Ther Health Med; 2023 Nov; 29(8):594-600. PubMed ID: 37678860
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEap1/NRF2 signaling.
    Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
    J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CX3CL1 induces cell migration and invasion through ICAM-1 expression in oral squamous cell carcinoma cells.
    Wu CY; Peng PW; Renn TY; Lee CJ; Chang TM; Wei AI; Liu JF
    J Cell Mol Med; 2023 Jun; 27(11):1509-1522. PubMed ID: 37082943
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK/HO-1 pathway activation.
    Yang WE; Chen YT; Su CW; Chen MK; Yeh CM; Chen YL; Tsai MY; Yang SF; Lin CW
    J Cell Mol Med; 2023 May; 27(9):1250-1260. PubMed ID: 36967712
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological study of pseudomyogenic hemangioendothelioma.
    Yang N; Huang Y; Yang P; Yan W; Zhang S; Li N; Feng Z
    Diagn Pathol; 2023 Feb; 18(1):25. PubMed ID: 36803395
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Network analysis reveals miRNA crosstalk between periodontitis and oral squamous cell carcinoma.
    Li Z; Fu R; Wen X; Zhang L
    BMC Oral Health; 2023 Jan; 23(1):19. PubMed ID: 36639776
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Narciclasine suppresses oral cancer metastasis by modulating cathepsin B and extracellular signal-related kinase pathways.
    Shieu MK; Ho HY; Lin CC; Lo YS; Chuang YC; Hsieh MJ; Chen MK
    Biomed Pharmacother; 2023 Feb; 158():114159. PubMed ID: 36577331
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A preliminary analysis of prognostic genes in advanced laryngeal squamous cell carcinoma patients with postoperative radiotherapy.
    Hu C; Lao Z; Yan L; Song X; Wang J
    Pathol Res Pract; 2023 Jan; 241():154229. PubMed ID: 36509010
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC.
    Deng T; Wang H; Yang C; Zuo M; Ji Z; Bai M; Ning T; Liu R; Wang J; Ge S; Zhang L; Ba Y; Zhang H
    Front Immunol; 2022; 13():1004345. PubMed ID: 36466860
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MicroRNA-217 aggravates breast cancer through activation of NF1-mediated HSF1/ATG7 axis and c-jun/ATF3/MMP13 axis.
    Li W; Yang C; Li J; Li X; Zhou P
    Hum Cell; 2023 Jan; 36(1):377-392. PubMed ID: 36357766
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma.
    Zhang Q; Gao Y; Zhang Y; Jing M; Wang D; Wang Y; Khattak S; Qi H; Cai C; Zhang J; Ngowi EE; Khan NH; Li T; Ji A; Jiang Q; Ji X; Li Y; Wu D
    Oncogene; 2022 Dec; 41(49):5238-5252. PubMed ID: 36310322
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. G2 and S phase-expressed-1 induces chromosomal instability in esophageal squamous cell carcinoma cells and inhibits cell apoptosis through ROS/JNK signaling.
    Zhang M; Wang X; Liu C; Zheng Z; Wan J; Yang Y; Chen S; Liu H
    Mol Carcinog; 2023 Feb; 62(2):122-134. PubMed ID: 36193884
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of transcription factor c-jun in hypopharyngeal squamous cell carcinoma: a 3-year follow-up retrospective study.
    Huang Q; Ye M; Li F; Lin L; Hu C
    BMC Cancer; 2022 Sep; 22(1):1019. PubMed ID: 36163022
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Reticulocalbin3: A Ca
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Hong C; Lin J
    Cancer Sci; 2022 Oct; 113(10):3593-3607. PubMed ID: 35839283
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity.
    Chien MH; Shih PC; Ding YF; Chen LH; Hsieh FK; Tsai MY; Li PY; Lin CW; Yang SF
    Expert Opin Ther Targets; 2022 Apr; 26(4):375-388. PubMed ID: 35361044
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.